Patent · US Active

Substituted 2-phenyl (AZA)benzofuran compounds for the treatment of hepatitis C

US10214534B2 · kind B2 · utility

0Cited by

2References

8Claims

0Family size

Assignee

Bristol-Myers Squibb Company · US

Inventors

Tao Wang · Farmington, US
Zhongxing Zhang · Wallingford, US
Kyle E. Parcella · Wallingford, US
Kyle J. Eastman · New Haven, US
John F. Kadow · Wallingford, US

Key dates

Filing date	Jun 10, 2015
Grant date	Feb 26, 2019
Priority date	—
Expiry date	Jun 10, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D491/04
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Compounds of Formula I, including their salts, as well as compositions and methods of using the compounds are set forth. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.